Ethanol Approval: A Major Regulatory Milestone for the BPR
Ethanol Approval: A Major Regulatory Milestone for the BPR
This week marks a major turning point as the European Chemicals Agency (ECHA) Biocidal Products Committee (BPC), during its February 2026 meeting, officially supported the approval of Ethanol for use in disinfectants. This positive opinion covers Ethanol for human hygiene, general surface disinfection, and food and feed area applications, spanning Product Types 1, 2, and 4. As Ethanol is an essential component in both professional healthcare settings and consumer hygiene products, this move toward formal approval provides the regulatory certainty needed to transition away from national transitional measures toward a more harmonized European framework.
However, while the BPC has confirmed Ethanol’s efficacy and general safety for these uses, the regulatory landscape remains nuanced. Crucially, the Committee noted that it did not take a definitive position on whether Ethanol should be formally classified as a carcinogenic or reprotoxic (CMR) substance in this specific biocidal context. For our clients, this “non-position” means that while the path to Union or National Authorization is now open, the underlying hazard profile remains a point of future scrutiny. We must remain vigilant regarding potential Classification, Labelling, and Packaging (CLP) updates, as any future shift toward a CMR 1A or 1B classification would trigger the BPR exclusion criteria and label Ethanol as a candidate for substitution (CfS). This makes it imperative for companies to not only prepare their dossiers for the upcoming approval date but also to consider the long term implications of exposure assessments and socio-economic arguments in their authorisations.
With the BPC opinion now finalised, the countdown to a formal European Commission Implementing Regulation has begun. Once the approval date is set, the window for submitting Biocidal Product Authorization applications will open, and the pressure on internal regulatory teams will increase. At Kerona, we are currently assisting partners in navigating this transition by performing detailed data gap analyses and streamlining Biocidal Product Families to ensure that formulations are compliant and market ready. Proactive planning today is the best way to manage the complexities of the post-approval era and ensure continued market access for these indispensable products.
For assistance with the authorisation of biocidal products or support for biocide applications and REACH, please do not hesitate to contact Kerona at info@kerona.ie or call us at +353 (0)1 849 5284.